|
GB9407447D0
(en)
|
1994-04-14 |
1994-06-08 |
Glaxo Group Ltd |
Chemical compounds
|
|
CA2262502C
(en)
|
1996-07-31 |
2002-11-26 |
Nikken Chemicals Co., Ltd. |
6-phenyltetrahydro-1,3-oxazin-2-one derivatives and pharmaceutical composition containing the same
|
|
US6610723B2
(en)
|
2001-01-29 |
2003-08-26 |
Hoffmann-La Roche Inc. |
Imidazole derivatives
|
|
KR20040111445A
(ko)
|
2002-03-28 |
2004-12-31 |
에자이 가부시키가이샤 |
신경퇴행성 질환 치료용 ｃ─Ｊｕｎ Ｎ─말단 키나아제억제제로서의 ７─아자인돌
|
|
US7005432B2
(en)
|
2002-05-16 |
2006-02-28 |
Hoffman-La Roche Inc. |
Substituted imidazol-pyridazine derivatives
|
|
AU2005214375A1
(en)
|
2004-02-18 |
2005-09-01 |
Astrazeneca Ab |
Triazole compounds and their use as metabotropic glutamate receptor antagonists
|
|
EP1805142A4
(en)
|
2004-09-23 |
2009-06-10 |
Reddy Us Therapeutics Inc |
PYRIDINE-BASED COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SAME
|
|
US7807704B2
(en)
|
2006-03-30 |
2010-10-05 |
Chemocentryx, Inc. |
Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2
|
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
KR20100017372A
(ko)
|
2007-05-25 |
2010-02-16 |
애보트 게엠베하 운트 콤파니 카게 |
향대사성 글루타메이트 수용체 2（ｍｇｌｕ2 수용체）의 포지티브 조절자로서의 헤테로사이클릭 화합물
|
|
WO2009004430A1
(en)
|
2007-06-29 |
2009-01-08 |
Pfizer Inc. |
N-benzyl oxazolidinones and related heterocycleic compounds as potentiators of glutamate receptors
|
|
WO2009028543A1
(ja)
|
2007-08-30 |
2009-03-05 |
Takeda Pharmaceutical Company Limited |
置換ピラゾール誘導体
|
|
WO2009058261A1
(en)
|
2007-10-31 |
2009-05-07 |
Merck & Co., Inc. |
Modulation of sleep with nr2b receptor antagonists
|
|
US20110053951A1
(en)
|
2008-03-27 |
2011-03-03 |
Evotec Neurosciences Gmbh |
Methods for treating disorders using nmda nr2b-subtype selective antagonist
|
|
EP2298731A4
(en)
|
2008-06-25 |
2011-09-21 |
Takeda Pharmaceutical |
AMIDE COMPOUND
|
|
DK2308877T3
(da)
|
2008-08-05 |
2014-04-22 |
Daiichi Sankyo Co Ltd |
Imidazopyridin-2-on-derivater
|
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
|
WO2010043396A1
(en)
|
2008-10-16 |
2010-04-22 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
|
|
KR101048448B1
(ko)
*
|
2008-11-21 |
2011-07-11 |
한국화학연구원 |
신규 피라졸로[4,3-ｂ]피리딘 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
|
|
CN102264743B
(zh)
|
2008-11-25 |
2015-02-11 |
罗彻斯特大学 |
Mlk抑制剂及其使用方法
|
|
US8969342B2
(en)
|
2009-03-20 |
2015-03-03 |
Brandeis University |
Compounds and methods for treating mammalian gastrointestinal microbial infections
|
|
EP2579717A4
(en)
|
2010-06-09 |
2013-12-11 |
Merck Sharp & Dohme |
POSITIVE ALLOSTERIC MODULATORS OF MGLUR2
|
|
JP2012188363A
(ja)
|
2011-03-09 |
2012-10-04 |
Dainippon Sumitomo Pharma Co Ltd |
アザベンゾイミダゾロン誘導体
|
|
WO2013060029A1
(en)
|
2011-10-28 |
2013-05-02 |
Merck Sharp & Dohme Corp |
Allosteric modulators of metabotropic glutamate receptors
|
|
WO2013130855A1
(en)
|
2012-03-02 |
2013-09-06 |
Takeda Pharmaceutical Company Limited |
Indazole derivatives
|
|
MA37975B2
(fr)
|
2012-09-11 |
2021-03-31 |
Genzyme Corp |
Inhibiteurs de synthase de glucosylcéramide
|
|
WO2014124651A1
(en)
|
2013-02-15 |
2014-08-21 |
Københavns Universitet |
Pyrrolidine-2-carboxylic acid derivatives as iglur antagonists
|
|
TW201444820A
(zh)
|
2013-03-13 |
2014-12-01 |
Abbvie Inc |
吡啶ｃｄｋ９激酶抑制劑
|
|
CN105073747B
(zh)
|
2013-03-15 |
2017-06-06 |
普莱希科公司 |
杂环化合物及其应用
|
|
KR102307566B1
(ko)
*
|
2013-06-21 |
2021-10-05 |
제니쓰 에피제네틱스 리미티드 |
신규한 바이사이클릭 브로모도메인 억제제
|
|
JP6612751B2
(ja)
|
2013-07-31 |
2019-11-27 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｂｔｋの阻害剤としてのピリジン、ピリミジン及びピラジンならびにその使用
|
|
PT3180315T
(pt)
|
2014-08-15 |
2020-05-27 |
Janssen Pharmaceuticals Inc |
Pirazoles
|
|
EP3180329B1
(en)
|
2014-08-15 |
2020-03-18 |
Janssen Pharmaceuticals, Inc. |
Triazoles as nr2b receptor inhibitors
|
|
WO2016081649A1
(en)
|
2014-11-18 |
2016-05-26 |
Emory University |
Thieno[2,3-d]pyrimidin-4-one derivatives as nmdar modulators and uses related thereto
|
|
MA41803A
(fr)
|
2015-03-24 |
2018-01-30 |
Almirall Sa |
Dérivés amino-indazoles utilisés comme inhibiteurs des canaux sodiques
|
|
MX2018000352A
(es)
|
2015-07-09 |
2018-08-15 |
Janssen Pharmaceutica Nv |
4-azaindoles sustituidos y su uso como moduladores del receptor glun2b.
|
|
KR20180108822A
(ko)
|
2016-02-10 |
2018-10-04 |
얀센 파마슈티카 엔.브이. |
Nr2b-선택적 nmda 조절제로서 치환된 1,2,3-트라이아졸
|
|
TW201819376A
(zh)
*
|
2016-10-06 |
2018-06-01 |
比利時商健生藥品公司 |
經取代之１Ｈ－咪唑並［４，５－ｂ］吡啶－２（３Ｈ）－酮及其作為ＧＬＵＮ２Ｂ受體調節劑之用途
|
|
CN110831593A
(zh)
|
2017-06-14 |
2020-02-21 |
特维娜有限公司 |
用于调节s1p1活性的化合物及其使用方法
|
|
EP3774732A4
(en)
|
2018-04-04 |
2022-02-09 |
Janssen Pharmaceutica NV |
PYRIDINE AND SUBSTITUTED PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS
|
|
CN110294756A
(zh)
|
2019-06-04 |
2019-10-01 |
广州市原子高科同位素医药有限公司 |
GluN2B亚基靶向型中枢神经系统正电子示踪剂及其制备
|
|
AU2020291188A1
(en)
|
2019-06-14 |
2022-01-20 |
Janssen Pharmaceutica Nv |
Substituted heteroaromatic Pyrazolo-pyridines and their use as GluN2B receptor modulators
|
|
US20220324860A1
(en)
|
2019-06-14 |
2022-10-13 |
Janssen Pharmaceutica Nv |
SUBSTITUTED PYRAZOLO[4,3-b]PYRIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS
|
|
EP3983413A1
(en)
|
2019-06-14 |
2022-04-20 |
Janssen Pharmaceutica NV |
Substituted pyrazolo-pyrazines and their use as glun2b receptor modulators
|
|
BR112021025132A2
(pt)
|
2019-06-14 |
2022-01-25 |
Janssen Pharmaceutica Nv |
Carbamatos de piridina e seu uso como moduladores do receptor glun2b
|
|
SG11202112407PA
(en)
|
2019-06-14 |
2021-12-30 |
Janssen Pharmaceutica Nv |
Substituted pyrazolo-pyridine amides and their use as glun2b receptor modulators
|
|
AU2020290772A1
(en)
|
2019-06-14 |
2022-01-06 |
Janssen Pharmaceutica Nv |
Pyrazine carbamates and their use as GluN2B receptor modulators
|